Medios AG (XETRA:ILM1.DE)
| Market Cap | 264.75M-27.8% |
| Revenue (ttm) | n/a+9.9% |
| Net Income | n/a-40.6% |
| EPS | n/a-40.8% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,887 |
| Open | 10.30 |
| Previous Close | 10.46 |
| Day's Range | 10.12 - 10.38 |
| 52-Week Range | 9.98 - 17.44 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Medios AG has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About ILM1.DE
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ILM1.DE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ILM1.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ILM1.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ILM1.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ILM1.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ILM1.DE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ILM1.DE
| ETF | Est. Holding Size |
|---|---|
| AVDEAvantis International Equity ETF | $134.68K |
| DISVDimensional - International Small Cap Value ETF | $131.60K |
| DFISDimensional - International Small Cap ETF | $35.06K |
| DFICDimensional - International Core Equity 2 ETF | $26.57K |
| AVDSAvantis International Small Cap Equity ETF | $20.40K |
| DFSIDimensional International Sustainability Core 1 ETF | $17.96K |
Estimated from each fund’s disclosed top holdings × AUM
ILM1.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ILM1.DE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score